Comments
Commented by Stefan Feulner on November 10th, 2025 | 07:15 CET
Newmont, Desert Gold Ventures, Coeur Mining – Further reasons for the rally to continue
Markets are nervous, with the DAX, Dow Jones, and Nasdaq all showing signs of peaking during last week's trading. Calls for a sharper correction, particularly due to the high valuations of AI stocks, are increasing. On the other hand, there are growing reasons for the recently paused gold rally to continue. The rising number of geopolitical flashpoints - most recently in Venezuela - is making the precious metal increasingly attractive as a safe haven.
ReadCommented by Nico Popp on November 10th, 2025 | 07:10 CET
Patient well-being as the key to returns: Oramed Pharmaceuticals, Roche, BioNxt
Higher, faster, further – constant progress is not only important in sports. The economy and science are also all about continuous innovation and improvement. Biotechnology combines both areas. We show how new, patient-centered approaches can capture market share and also create added value for investors. To this end, we take a look at the Swiss pharmaceutical company Roche, show how the Israeli biotech company Oramed has learned from setbacks, and how BioNxt Solutions is securing promising patents with innovative dosage forms.
ReadCommented by Armin Schulz on November 10th, 2025 | 07:05 CET
Silver North Resources is benefiting from high silver prices and will be able to supply JinkoSolar and Xiaomi in the future
Demand for silver is driving prices to unprecedented heights. As an indispensable raw material for solar cells, electronics, and electromobility, a production deficit is now emerging that is bringing the precious metal increasingly into focus. For consumers, this could become a cost trap, while at the same time opening up a unique opportunity for investors. The real winners are clear: those companies that extract the coveted metal from the earth. This dynamic development brings together three players in a special constellation. The explorer Silver North Resources is a potential beneficiary, and the bulk buyers JinkoSolar and Xiaomi are drivers of demand.
ReadCommented by André Will-Laudien on November 10th, 2025 | 07:00 CET
Takeover fever! BYD is amazed, Graphano celebrates, and Lyft buys FreeNow from Mercedes and BMW!
If the electric vehicle market wants to overtake combustion engines, further advances in battery technology are still needed. Consumers need to be convinced, which means that economic realities should be at the forefront of their purchasing decisions. Major innovations require high-performance materials, including graphite, which is a key component of modern lithium-ion batteries. Graphite contributes to a greater range, higher energy density, and improved safety. At the same time, innovative approaches to silicon anodes and novel cathode materials are ensuring more efficient and cost-effective production processes. With the steady expansion of charging infrastructure, range anxiety among consumers is diminishing, further boosting the adoption of e-mobility. This highly dynamic innovation environment thus opens up attractive prospects for both technology developers and investors, as the industry is changing rapidly.
ReadCommented by André Will-Laudien on November 7th, 2025 | 07:50 CET
Fact check: After the correction comes the next rally! Ups and downs for Almonty, Aixtron, and Deutsche Pfandbriefbank
Zigzag! Buy, sell, buy again! What wild volatility we are seeing on the trading board! Palantir delivers dream numbers, exceeding analysts' estimates by 10%, only to drop 20% after a brief rally. Traders have a saying for this: "Buy the rumor, sell the fact." Indeed, this kind of market behavior is often seen around earnings releases. In the case of Almonty, the stock surged an explosive 700% in just eight months, only to lose 40% in the subsequent correction. For flexible investors, it is worth taking a closer look and not losing sight of the fundamentals. Here are a few ideas for rocking the boat or tucking stocks away à la Kostolany!
ReadCommented by Armin Schulz on November 7th, 2025 | 07:05 CET
BYD and Graphano Energy are driving the energy storage revolution - even Nordex is benefiting indirectly
The energy landscape is undergoing radical change. The key no longer lies solely in the generation of green electricity, but in its intelligent storage and use. Electric vehicles are mutating into rolling power tanks that can stabilize grids, while extensive stationary storage facilities compensate for the fluctuating feed-in from wind and solar power. This revolution opens up massive savings potential for consumers and reduces the need for expensive grid upgrades. We take a look at whether BYD, Graphano Energy, and Nordex can benefit from this booming ecosystem.
ReadCommented by Fabian Lorenz on November 7th, 2025 | 07:00 CET
Takeover battle between Novo Nordisk and Pfizer! Is BioNxt Solutions the next target?
Who will acquire Metsera? That is currently the subject of dispute between Novo Nordisk and Pfizer. Both pharma giants are seeking access to a new generation of metabolic therapies through the acquisition - treatments that have the potential to transform the billion-dollar market for obesity and diabetes care. Novo Nordisk views Metsera's drug pipeline as a complement to its GLP-1-based preparations, while Pfizer is trying to finally gain a foothold in the market after several setbacks. The takeover battle illustrates that big pharma companies are willing to dig deep into their pockets for innovations. This makes BioNxt Solutions a potential takeover candidate. The Company is not only working on innovations in the field of multiple sclerosis and obesity, but on an entire platform technology.
ReadCommented by Armin Schulz on November 6th, 2025 | 07:55 CET
Take advantage of setbacks among industry leaders: A strategic entry into Almonty Industries, Rheinmetall, and D-Wave Quantum
During a phase of global market corrections, which has now also reached the US markets, true investor quality becomes evident. While weak hands see volatility as a threat, strategists recognize it as a valuable opportunity: the chance to position robust companies with clear competitive advantages and long-term growth trajectories at temporarily reduced prices. This pattern of strategic entries following setbacks among industry leaders is currently particularly evident at Almonty Industries, Rheinmetall, and D-Wave Quantum.
ReadCommented by André Will-Laudien on November 6th, 2025 | 07:10 CET
Novo Nordisk calculating carefully, Evotec facing potential takeover? Clinical trial and up-listing at Vidac!
The stock market is showing some turbulence in the biotech sector. Unlike the big growth stocks on the NASDAQ, there is still urgent catching-up to do here. Some figures, such as those from Novo Nordisk and Evotec, still give reason for concern. The situation is quite different at Vidac Pharma, where an up-listing to the primary market is on the horizon and a clinical trial is about to begin! Plenty of material for investors' dreams to grow. We calculate where an investment is worthwhile!
ReadCommented by Carsten Mainitz on November 6th, 2025 | 07:05 CET
Totally underestimated! These are the secret winners of the AI and energy revolution: Power Metallic Mines, Aixtron, and Siemens Energy!
Forget most of the hyped stocks in the AI and tech space. The most significant gains in the current tech and energy transition boom come - not from the diggers, but from the suppliers - just like during the Gold Rush in the 19th century. While billions are being poured into the hunt for digital gold (artificial intelligence) and green gold (renewable energy), the (emerging) raw material producers, specialized machinery manufacturers, and infrastructure providers are the ones benefiting most. We show you the overlooked profiteers of the boom!
Read